Bayer Crop Science Share News - Latest Updates, Live News & More

Latest news about Bayer Crop Science

Bayer Cropscience Ltd. Records Rs. 24.12 Crore NSE Block Trade at Rs. 4777.50 Per Share 4 hrs ago Today

Bayer Cropscience Ltd. executed a significant NSE block trade worth Rs. 24.12 crores involving approximately 50,486 shares at Rs. 4777.50 per share. The transaction represents substantial institutional activity and provides insights into large investor positioning in the agricultural sciences company.

Bayer CropScience receives Rs. 0.16 million penalty order for E-way bill documentation from UP authority 5 days ago

Bayer CropScience Limited Receives Rs. 29.83 Million Penalty Order from Odisha Tax Authorities for E-way Bill Documentation 9 days ago

Bayer CropScience Limited Receives Rs. 11.87 Million GST Penalty Order from Ahmedabad Authority Mar 27, 2026

Bayer CropScience Limited Receives ESG Rating of 67.1 from SES ESG Research Mar 20, 2026

More news about Bayer Crop Science

20Mar 26

Bayer Cropscience Ltd. Records Rs. 22.86 Crore Block Trade on NSE

Bayer Cropscience Ltd. completed a block trade worth Rs. 22.86 crores on NSE, involving approximately 50,585 shares at Rs. 4519.30 per share. The transaction represents significant institutional activity and was executed outside regular trading to minimize market impact.

19Mar 26

Bayer CropScience Opens Special Window for Physical Share Transfer and Dematerialisation

Bayer CropScience Limited has opened a special window from February 05, 2026 to February 04, 2027 for transfer and dematerialisation of physical securities sold/purchased prior to April 01, 2019. The facility, announced through newspaper advertisements on March 19, 2026, follows SEBI regulatory requirements and also covers previously rejected transfer requests. Shareholders must submit documents to RTA MUFG Intime India Private Limited, with transferred securities to be credited only in demat mode and subject to one-year lock-in period.

22Jan 26

Bayer CropScience wins appeal against ₹100 million customs penalty, tribunal sets aside original order

Bayer CropScience Limited successfully appealed a ₹100 million customs penalty, with CESTAT setting aside the original order on January 20, 2026. The tribunal ruling also quashed demands for ₹13 million in export incentive recovery and additional penalties, with no settlement amount paid and no adverse financial impact on the company.

16Dec 25

Bayer CropScience Receives Rs 1.55 Million GST Penalty for FY 2018-19

Bayer Crop Science Limited has received a penalty order of Rs 1.55 million from the Office of the Superintendent of Central Tax, Amaravathi CGST Division for GST violations related to outward supply in FY 2018-19. The company disclosed this information under SEBI Regulation 30 and stated the order is appealable, with plans to assess exercising their right to appeal.

29Nov 25

Bayer CropScience Receives Revised GST Order with Reduced Penalty

Bayer Crop Science received a revised order from the Additional Commissioner of Central Tax, GST Commissionerate, Belagavi, Karnataka, reducing the penalty for GST on Outward Supply for FY 2017-18 from INR 74.00 million to INR 31.00 million, a 58.11% reduction. The company is evaluating options, including the possibility of appealing the revised order.

28Nov 25

Bayer Crop Science Targets Growth Amid Challenges: Analyst's Take on Strategic Framework

Bayer Crop Science Limited has announced its strategic framework for the next 3-5 years, targeting high single-digit to low double-digit revenue growth and 100 basis points margin improvement. The company reported 3% revenue growth in H1 FY2026, with strong performance in corn seeds. However, Q2 faced challenges due to persistent rains. The strategy includes doubling the corn seeds business, launching new products like BICOTA and EtcioStar, and optimizing go-to-market strategies. Recent financial data shows pressure on profitability, with net profit declining 73.12% YoY in H1 FY2026 compared to full-year FY2025 results.

25Nov 25

Bayer CropScience Unveils 5-Year Strategic Framework Amid Financial Headwinds

Bayer Crop Science presented a 5-year strategic framework in an investor meeting, focusing on corn market leadership, rice portfolio scaling, digital transformation, new product launches, and enhanced go-to-market strategies. The company reported a 7.19% increase in revenue to ₹5,473.40 crore, but faced profitability challenges with net profit declining by 23.30% to ₹568.00 crore. Operating profit margin decreased from 18.74% to 12.60%, indicating cost pressures. The company aims to strengthen its market position through innovation and improved distribution strategies, while navigating challenges such as margin pressure, competition, and regulatory environment.

07Nov 25

Bayer Cropscience Declares Rs. 90 Interim Dividend Amid Mixed Q2 Results

Bayer Cropscience announced an interim dividend of Rs. 90 per share, totaling Rs. 4,045 million, payable on December 3, 2025. Q2 FY2025-26 results show a 10.6% decline in revenue to Rs. 15,534 million, but improved profitability with EBITDA up 13.9% to Rs. 2,050 million and net profit increasing 12.5% to Rs. 1,530 million. The EBITDA margin expanded by 264 basis points to 13.22%. The company operates in the 'Agri Care' segment and reported total assets of Rs. 51,910 million as of September 30, 2025.

03Sept 25

Bayer CropScience CEO Cautious on FY26 Outlook Despite India's Agricultural Potential

Bayer CropScience CEO Simon-Thorsten Wiebusch expressed measured optimism for the company's fiscal year 2026 outlook, balancing erratic monsoons against India's untapped agricultural market potential. The year started strong, but inconsistent rainfall patterns have introduced uncertainty. September's weather is crucial for the kharif season, while the rabi season outlook is more positive due to well-filled dams and stable commodity prices. Wiebusch highlighted India's significant growth potential as an under-penetrated market. He noted that gross margin pressures, particularly related to glyphosate pricing, may be easing. However, external factors like industrial overcapacity in China could still impact the Indian market.

06Aug 25

Bayer CropScience Reports Robust Q1 Performance with 17% Revenue Growth

Bayer Crop Science announced robust Q1 financial results, with revenue increasing 17% to ₹19,146.00 million and net profit rising 10% to ₹2,787.00 million. EBITDA improved to ₹3,671.00 million, though the EBITDA margin slightly decreased to 19.2%. The strong performance was attributed to early monsoon onset, higher volumes in corn seeds and Roundup® herbicide, and the successful launch of BICOTA® for paddy cultivation. The company observed signs of input cost stabilization and maintained focus on cost discipline despite elevated operating expenses.

27May 25

Bayer CropScience: Q4 Profit Surges 49%, Declares ₹35 Dividend

Bayer CropScience's Q4 results show significant growth with net profit rising 49% to ₹143.30 crore. Revenue from operations increased to ₹1,046.40 crore. The company recommended a final dividend of ₹35 per share. Full-year revenue grew to ₹5,473.40 crore despite challenges like unpredictable monsoons and higher input costs.

26May 25

Bayer CropScience Q4 Profit Soars 46% to ₹1.4 Billion, Revenue Up 32%; Recommends Final Dividend

Bayer CropScience has reported strong Q4 results with net profit rising 46% year-over-year to ₹1.40 billion and revenue increasing 32% to ₹10.50 billion. The company's quarter-on-quarter net profit grew by 309%. Despite a slight decline in annual figures, the Q4 performance indicates positive momentum. A final dividend of ₹35 per share has been recommended.